Global consensus statement on menopausal hormone therapy

Climacteric. 2013 Apr;16(2):203-4. doi: 10.3109/13697137.2013.771520.

Abstract

The following Consensus Statement is endorsed by The American Society for Reproductive Medicine, The Asia Pacific Menopause Federation, The Endocrine Society, The European Menopause and Andropause Society, The International Menopause Society, The International Osteoporosis Foundation and The North American Menopause Society.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms
  • Consensus*
  • Coronary Disease / prevention & control
  • Estrogen Replacement Therapy* / adverse effects
  • Estrogen Replacement Therapy* / methods
  • Estrogens / administration & dosage
  • Estrogens / adverse effects
  • Female
  • Fractures, Bone / etiology
  • Fractures, Bone / prevention & control
  • Humans
  • Menopause*
  • Middle Aged
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / prevention & control
  • Progestins / administration & dosage
  • Progestins / adverse effects
  • Quality of Life
  • Risk Factors
  • Stroke / epidemiology
  • Thromboembolism / epidemiology

Substances

  • Estrogens
  • Progestins